 Morgan Stanley lowered its stake in shares of Immunomedics, Inc. NASDAQ:IMMU by 53.4 during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 321,122 shares of the biopharmaceutical companys stock after selling 368,259 shares during the quarter. Morgan Stanley owned about 0.14 ... 